Filing Details

Accession Number:
0001104659-11-012545
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-03-04 20:46:27
Reporting Period:
2011-03-02
Filing Date:
2011-03-04
Accepted Time:
2011-03-04 20:46:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1131324 Genomic Health Inc GHDX Services-Medical Laboratories (8071) 770552594
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201580 D Samuel Colella C/O Versant Ventures
3000 Sand Hill Road, #4-210
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-03-02 505,571 $0.00 1,082,174 No 4 J Indirect Versant Venture Capital I, L.P.
Common Stock Disposition 2011-03-02 10,109 $0.00 20,838 No 4 J Indirect Versant Side Fund I, L.P.
Common Stock Acquisiton 2011-03-02 4,300 $0.00 8,726 No 4 J Indirect Colella Family Partners, L.P.
Common Stock Acquisiton 2011-03-02 8,753 $0.00 17,757 No 4 J Indirect Colella Family Trust UTA Dtd. 9/21/92
Common Stock Disposition 2011-03-03 10,571 $25.45 19,358 No 4 S Indirect Versant Affiliates Fund I-A, L.P.
Common Stock Disposition 2011-03-03 23,749 $25.45 37,552 No 4 S Indirect Versant Affiliates Fund I-B, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Indirect Versant Venture Capital I, L.P.
No 4 J Indirect Versant Side Fund I, L.P.
No 4 J Indirect Colella Family Partners, L.P.
No 4 J Indirect Colella Family Trust UTA Dtd. 9/21/92
No 4 S Indirect Versant Affiliates Fund I-A, L.P.
No 4 S Indirect Versant Affiliates Fund I-B, L.P.
Footnotes
  1. The Reporting Person is a managing member of Versant Ventures I, LLC ("VVI-LLC"), which is the general partner of each of Versant Side Fund I, L.P., Versant Venture Capital I, L.P., Versant Affiliates Fund I-A, L.P., and Versant Affiliates Fund I-B, L.P. (collectively, the "Versant Funds"). As such, the Reporting Person shares voting and investment power over the shares held by the Versant Funds and may be deemed to have indirect beneficial ownership of such shares. Versant Venture Capital I, L.P. made an in-kind distribution of 505,571 shares of common stock of the Issuer to their respective partners on March 2, 2011. Versant Side Fund I, L.P. made an in-kind distribution of 10,109 shares of common stock of the Issuer to their respective partners on March 2, 2011. The Reporting Person disclaims beneficial ownership of such shares held by the Versant Funds, except to the extent of his proportionate pecuniary interest therein, if any.
  2. The shares are held by Colella Family Partners, L.P. ("Colella Partners"). The shares were received in in-kind distributions of 4,098 shares by Versant Venture Capital I, L.P. and 202 shares by Versant Side Fund I, L.P. on March 2, 2011. The Reporting Person is the General Partner of Colella Partners. The Reporting Person disclaims beneficial ownership of such shares held by Colella Partners, except to the extent of his proportionate pecuniary interest therein, if any.
  3. The shares are held by the Colella Family Trust UTA Dtd. 9/21/92 ("Colella Trust"). The shares were received in in-kind distributions of 8,197 shares by Versant Venture Capital I, L.P. and 556 shares by Versant Side Fund I, L.P. on March 2, 2011. The Reporting Person is a trustee and beneficiary of the Colella Trust.
  4. Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $25.45 to $26.08 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.